| Predicate |
Object |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4402
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0002
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2095
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61J3-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2054
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2018 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4402
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-16 |
| filingDate |
2011-09-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate |
2013-08-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
EA-201390464-A1 |
| titleOfInvention |
Method of dry treatment of atazanavir |
| abstract |
The invention relates to methods for the dry preparation of oral dosage forms, more specifically tablets containing atazanavir as the active compound and adhesion promoters. The invention also concerns compacted intermediates containing atazanavir and adhesion promoters. |
| priorityDate |
2010-09-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |